Successfully Commercializing Alternative Proteins – Bench to Plate with Mark Warner

EVENT DESCRIPTION: Alternative protein companies face significant challenges in scaling-up their promising technologies from benchtop to commercial reality. Technology scale-up represents the largest portion of funding required to bring a novel product to market and is often an area where founders have less experience. Seasoned industry consultant Mark Warner will provide an introduction to scale-up challenges in the alternative protein industry and how they impact fundraising. The 30 minute presentation is followed by 20 minutes of audience Q&A. Topics include: 1. What is scale-up and how can risk be minimized? A practical look at the goals and typical costs for each stage of the process. 2. How do operational economics impact scale-up options? Discussion of the economics of various stages of scale-up and how they impact fundraising. 3. Lessons learned? What differentiates novel technologies that have reached commercial scale to those that failed. 4. Case Study: Real world examples of common scale-up challenges. MEET OUR PRESENTER: Mark Warner is an industry leader with significant experience in commercialization of first-of-a-kind biotechnologies from bench-top to commercial reality. He has held executive level positions for leading advanced biotechnology companies including Impossible Foods and Solazyme. His primary focus is on cellular agriculture and he has consulted with over 50 startup companies working to bring novel biotechnologies to commercial scale. He is a registered professional chemical engineer and the Founder of Warner Advisors LLC.